The Institute for Clinical and Economic Review has published protocol for its annual “Unsupported Price Increases” report. Some changes include clarification of the submission process and information required of drug makers, expansion of the initial list to 250 drugs, and the CPI threshold. ICER, which has been publishing the UPI report since 2019, proposes to generate a final list of up to 13 prescription drugs with substantial price increases between 2019 and 2020. The first step is identifying the 250...